Enforcement in Brief
This article was originally published in The Gold Sheet
A consent decree brings Downing Labs to heel, while Pfizer JV partner Zhejiang Hisun gets a warning letter and a shortage-related reprieve on import alert. Meanwhile, Ipca is hit with a warning letter, Chan Yat Hing’s cosmetics ploy is blocked, and two Chinese firms get import alerts.
You may also be interested in...
Demand surges, supply surges and investigator travel restrictions are forcing FDA to adopt less restrictive regulatory approaches during the pandemic.
Pan Drugs told FDA it would divert dirty plant’s API to India; Zhejiang Hisun reels from import alert, warning letter; Impax resolves warning letter; Polydrug and Akorn put on import alert; and TxCell outsources GMP problems away.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.